The present invention relates to new compounds of formula I,
where R1 and R2 are independently halo or C1-3haloalkyl,
X is ethenyl or ethynyl,
or a salt thereof.
The present invention relates to new compounds of formula I,
where R
1
and R
2
are independently halo or C
1-3
haloalkyl,
X is ethenyl or ethynyl,
or a salt thereof.
NOVEL SPIRO[IMIDAZOLIDINE-4,3'-INDOLE]-2,2',5(1'H)-TRIONES FOR TREATMENT OF CONDITIONS ASSOCIATED WITH VANILLOID RECEPTOR 1
申请人:AstraZeneca AB
公开号:EP2013215A2
公开(公告)日:2009-01-14
US7868181B2
申请人:——
公开号:US7868181B2
公开(公告)日:2011-01-11
[EN] NEW COMPOUNDS II<br/>[FR] NOUVEAUX COMPOSÉS II
申请人:ASTRAZENECA AB
公开号:WO2007091947A2
公开(公告)日:2007-08-16
(EN) The present invention relates to new compounds of formula I, where R1 and R2 are independently halo or C1-3haloalkyl, X is ethenyl or ethynyl, or a salt thereof.(FR) L'invention concerne des nouveaux composés de formule I, dans laquelle R1et R2 représentent de façon indépendante un halo ou un haloalkyle en C1-3, X représente un éthényle ou éthynyle, ou un de leur sel.